Events

CSL is a leading global biotech company that develops and delivers innovative biotherapies to help people living with life-threatening medical conditions live full lives.

CSL’s Research Acceleration Initiative aims to fast-track discovery of innovative biotherapies through partnerships between CSL and global research organizations.

Successful applicants will receive funding of up to $400,000 USD over 2 years.

Interested researchers are invited to:

• Attend information webinars to learn more about the initiative: Thursday, January 23 at 1pm ET or Wednesday, February 5, at 11am ET
• Contact James Bellush at jmb824@cornell.edu to express interest in applying and to obtain online application submission instructions.
• Submit a non-confidential, 300 word abstract via the CSL online application portal by February 20, 2025.

In the past, obtaining an issued patent from the U.S. Patent and Trademark Office usually meant wrangling with a patent examiner over the pillars of patentability, novelty and obviousness. However, the Supreme Court's 2023 decision in Amgen v. Sanofi thrust another lesser-known condition, the enablement requirement, to the forefront. Citing the enablement requirement, the Court curtailed the breadth of the Amgen's patent claims, stating that the specification did not support their broad claims to classes of molecules. In the aftermath, inventors, patent holders and practitioners have been left scrambling to figure out how this new interpretation of enablement affects them.

Join us for a webinar with Yvonne Shyntum, Partner at PABST Patent Group, as she walks through the Court's interpretation of enablement and practical strategies for complying with enablement. Dr. Shyntum holds a Ph.D. in Molecular and Systems Pharmacology from Emory University and a J.D. from Georgia State University. She represents clients in the biotechnology and pharmaceutical areas and regularly presents on intellectual property topics. 

Register here. 

You are invited to attend our second virtual info session for the Susan and Gene D. Resnick ’70, MD ’74 Prize for Excellence in Entrepreneurship (“Resnick Prize”). The Resnick Prize is an annual, university-wide competition that provides funding to startups with an active, intercampus collaboration involving Weill Cornell Medicine and another Cornell University campus/location in Ithaca, New York, or Qatar. Startups initiated at Weill Cornell, Cornell Ithaca, Cornell Tech, or WCM-Qatar are eligible to apply as long as the startup has a license to Cornell-owned technology that touches Weill Cornell Medicine through either a research or clinical collaboration.  

We are seeking exciting collaborations where teams can work together on a technology that will be commercialized via a startup. The winning company will receive up to $10,000 in prize money.

The Resnick Prize seeks to fund projects in all sectors (therapeutics, devices, digital health, research & AI tools, etc.) impacting healthcare and patient outcomes. Teams must have incorporated their company to be eligible for the award. 

The deadline for applications is Friday, February 14.

Register for the info session here. 

Applications are open for the Summer 2025 Prototyping Hardware Accelerator at Rev: Ithaca Startup Works! 

Over 10 weeks, Rev’s in-person Prototyping Hardware Accelerator guides product teams to determine if their ideas are commercially desirable, technologically feasible, and economically viable. Upon completion of the program, participants are positioned to recruit team members, bring on partners, initiate work with contract manufacturers, and pitch to investors. Teams will receive a stipend of up to $2,000 to advance their prototype. 

Want to learn more? Register to attend an upcoming virtual information session. Questions? Contact rev@revithaca.com.

Please join the Sanders Tri-Institutional Therapeutics Discovery Institute (Sanders TDI) for a webinar on accelerating your academic drug discovery. This webinar will provide an overview of our process and how Sanders TDI can help translate your discoveries into new drugs. We will have a panel of our experts present to answer any questions you might have. 

Join the webinar using the link here. For more information, please email Sanders TDI at info@tritdi.org.  

In this hybrid course (February 10 - March 12), a select group of researchers working on digital healthcare technology will "get out of their comfort zone" and talk to customers at the Healthcare Information and Management Systems Society (HIMSS) conference to identify the best product-market fit. The course begins online and culminates with a trip to Las Vegas, NV for the 2025 HIMSS Conference. Up to $5,000 (depending on team size) in travel reimbursement funding will be available for accepted teams*.

You may apply with a team of 1-3 people. Teams may not split attendance between members. Please only include the members of your team that will be fully participating in the course. All team members are required to attend and participate fully in every course session and complete all coursework.

Apply here. Questions? Contact icorps@cornell.edu. 

In this virtual course (held February 10 - March 12), researchers working on a deep tech innovation “get out of your comfort zone” and talk with customers (virtually) to identify the best product-market fit. You may apply with a team of 1-3 people. Teams may not split attendance between members. Please only include the members of your team that will be fully participating in the course. All team members are required to attend and participate fully in every course session and complete all coursework.

Apply here. Questions? Contact icorps@cornell.edu. 

Join us for a virtual info session for the Susan and Gene D. Resnick ’70, MD ’74 Prize for Excellence in Entrepreneurship (“Resnick Prize”). The Resnick Prize is an annual, university-wide competition that provides funding to startups with an active, intercampus collaboration involving Weill Cornell Medicine and another Cornell University location in Ithaca, New York, or Qatar. Startups initiated on the Weill Cornell, Cornell Ithaca, Cornell Tech, or Weill Cornell Medicine - Qatar campuses are eligible to apply as long as the startup has a license to Cornell-owned technology that touches Weill Cornell Medicine through either a research or clinical collaboration.

We are seeking exciting collaborations where teams can work together on a technology that will be commercialized via a startup. The winning company will receive up to $10,000 in prize money.

The Resnick Prize seeks to fund projects in all sectors (therapeutics, devices, digital health, research & AI tools, etc.) impacting healthcare and patient outcomes. Teams must have incorporated their company to be eligible for the award.  

Please RSVP for this info session to learn more about the application process and eligibility.

Join Enterprise Innovation for an annual celebration of innovation and entrepreneurship hosted by Dean Robert A. Harrington! The symposium features: 

• An inspiring talk with Dr. Rachel Haurwitz, co-founder, president and CEO of Caribou Biosciences and inventor on patents covering multiple CRISPR-based technologies
• Presentations and panel discussions with Weill Cornell innovators
• Office Hours with Enterprise Innovation team
• Celebration of Daedalus Fund for Innovation & Selma and Lawrence Ruben Science to Industry Bridge Fund awardees
• Reception and networking

RSVP: https://deanssymposium.eventbrite.com/

Calling pre-seed and seed innovators and entrepreneurs in Oncology, Cell & Gene Therapy, Cardiovascular, Immunology, Radiology, and Digital Health!

Do you have disruptive science but struggle to bring it to life in the entrepreneurial world? Bayer's passion is to enable and support standout healthcare innovation.

Take your innovation to new heights and join Bayer's Expert Mondays 2024, a series of knowledge exchange sessions to supercharge your startup’s growth.

Each one-hour Bayer's Expert Monday includes a live Q&A with respective Bayer Experts. You can stay for a Meet & Greet with Bayer Scouts and Scientific Finders. Please reserve 30 additional minutes in your schedule for the Meet & Greet after the Bayer Expert session.

These sessions are not intended for service providers, consultants, IT providers, etc. They are designed for drug developers and healthcare researchers seeking collaboration with big pharma and out-licensing opportunities later in their journey. Session recordings are NOT distributed afterward. Live attendance is necessary to get the most out of the expert sessions and network with the Bayer Pharma team.

The Dec 9 event features Nicolas Becker and Jeremy Booth, Senior Directors BD&L, Alliance Management. Reserve your spot here.